Roadzen has agreed to sell 4,705,870 ordinary shares at $1.70 per share to institutional investors, generating gross proceeds of approximately $8.0 million. The offering is structured as a registered direct under the company’s S-3 shelf registration declared effective November 12, 2024, and is expected to close around May 5, 2026.

The net proceeds, after placement agent fees and expenses, will bolster Roadzen’s cash runway, likely supporting ongoing AI development in insurance and mobility risk management. The deal’s dilution impact on existing shareholders will depend on total outstanding shares and could weigh on short-term trading dynamics.